angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with Cardiac Toxicity in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Guan, J; Luo, S; Yan, J; Yang, L; Yang, P; Zhang, X; Zhong, C | 1 |
1 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and Cardiac Toxicity
| Article | Year |
|---|---|
Angiotensin IV ameliorates doxorubicin-induced cardiotoxicity by increasing glutathione peroxidase 4 and alleviating ferroptosis.
Topics: Animals; Apoptosis; Atrophy; Cardiotoxicity; Doxorubicin; Ferroptosis; Humans; Mice; Myocytes, Cardiac; Oxidative Stress; Phospholipid Hydroperoxide Glutathione Peroxidase | 2023 |